Aim and Scope

Defining the clinical and public health focus of JCRHAP.

JCRHAP advances HIV/AIDS science by publishing clinically relevant research that improves prevention, diagnosis, treatment, and long term care.

We prioritize rigorous methodology, measurable outcomes, and evidence that supports clinical decision making and public health policy.

The journal covers clinical trials, prevention science, epidemiology, implementation research, and health systems interventions focused on HIV/AIDS.

Submissions should demonstrate clear relevance to HIV prevention, treatment outcomes, or care delivery.

• Antiretroviral therapy outcomes and optimization
• Pre exposure prophylaxis and post exposure strategies
• HIV testing, linkage to care, and retention
• Coinfections and comorbidity management
• Maternal and pediatric HIV care
• Behavioral and community prevention programs
• Implementation science and care delivery models

• Randomized clinical trials and pragmatic studies
• Prospective and retrospective cohort studies
• Systematic reviews and meta analyses
• Implementation and health systems research
• Program evaluations with measurable outcomes

Manuscripts should define primary outcomes, follow up duration, and patient safety considerations. Clear outcome reporting strengthens clinical relevance and policy impact.

When applicable, include patient reported outcomes and adherence or retention metrics.

Provide transparent methods, statistical reporting, and data availability statements. Clinical studies should include ethics approvals and trial registration identifiers when required.

Use reporting standards such as CONSORT, STROBE, or PRISMA based on study design.

• HIV focus is clear in title and abstract
• Methods and outcomes align with study aims
• Ethics approvals and consent documented
• Data availability statement included
• Clinical or public health implications are described

Studies focused solely on non HIV conditions without a clear HIV/AIDS contribution are out of scope. Manuscripts must demonstrate relevance to HIV prevention, treatment, or care outcomes.

JCRHAP emphasizes transparent methods and reproducible reporting. Manuscripts should clearly describe study design, cohort selection, intervention protocols, and outcome definitions.

We encourage authors to document analytic decisions, adherence measures, and follow up intervals. Clear reporting strengthens evidence quality and improves clinical interpretation.

Using structured reporting standards improves peer review efficiency and supports long term reuse of HIV/AIDS evidence.

• Use CONSORT, STROBE, or PRISMA
• Report adverse events and limitations
• Define primary and secondary outcomes
• Document follow up duration
• Provide transparent data statements

The editorial office supports authors with scope checks, formatting guidance, and policy clarifications before and after submission. Early communication prevents delays and helps manuscripts meet HIV/AIDS research standards.

Authors receive clear decision letters and may request clarification on reviewer feedback or revision priorities. The team can advise on file preparation, data statements, and reporting standards.

For workflow questions or guidance on special issues, contact [email protected] and include the manuscript title and journal name.

• Scope check support before submission
• Guidance on reporting standards
• Help with data availability statements
• Clarification on revision expectations
• Support during proof review

Open access publishing increases the reach of HIV/AIDS research across clinical, academic, and public health communities. Articles are immediately accessible to clinicians, program leaders, and policy teams.

JCRHAP supports DOI registration and metadata quality checks to improve discoverability and citation tracking. Clear titles and structured abstracts strengthen search visibility.

Authors can increase impact by sharing DOI links, depositing datasets, and communicating findings through professional networks.

• DOI registration for permanent access
• Metadata validation for indexing
• Open access for global readership
• Support for institutional reporting
• Guidance on sharing published work

Submissions move through initial screening, peer review, revision, and production. Each stage includes quality checks to ensure ethical compliance and accurate reporting.

JCRHAP aims to deliver decisions within the 2 to 4 week review window, depending on reviewer availability and manuscript complexity. Prompt author responses help keep timelines on track.

After acceptance, articles proceed to copyediting, proof review, and DOI registration before publication.

• Initial screening for scope and ethics
• Single blind peer review by experts
• Revision cycle based on reviewer input
• Production with copyediting and proofs
• Publication after final approval